This course is intended for healthcare professionals practicing in Cardiology.
There are 10 questions post-webinar, and these will require a pass mark of 70% or higher to collect credit.
This educational activity is free of charge.
Expanding Patient Outcomes in Hypertrophic Cardiomyopathy Care
Take part in this EMJ Learning CME accredited course where two expert faculty members will guide you through the latest treatment advancements for patients with Hypertrophic Cardiomyopathy (HCM).
Following this course you will be able to:
- Discuss the burden of HCM, including its prevalence worldwide
- Summarise the pathophysiology underlying HCM, and how this can impair cardiac output.
- Describe the heterogeneous nature of HCM, including the wide variety of symptoms and severities.
- Explain the importance of prompt diagnosis and the impact of appropriate treatment for improved patient outcomes.
- Discuss the current treatment options for HCM, including new targeted treatment approaches, analysing their advantages and limitations.
Professor Theodore Abraham
University of California San Francisco, UCSF Echocardiography laboratory and the UCSF HCM Center of Excellence
Disclosures: Research grant to institution from: BMS, Cytokinetics, Tenaya, Edgewise, Imbria.
Dr Michelle Michels
Erasmus MC Center of Expertise for Inherited Cardiovascular Diseases, Rotterdam, the Netherlands
Disclosures: Research grant from Bristol Myers Squibb; and consultancy and speaker fees from Bristol Myers Squibb, Cytokinetics, Alnylam, and Bayer.
Information:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) through the joint providership of Mind Hill and EMJ Learning. The European Board for Accreditation of Continuing Education for Health Professionals (EBAC) accredits Continuing Education (CE) programmes for the international medical community. Mind Hill is an EBAC accredited provider since 2023.
This activity is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1:00 hour of effective education time, and is designated for 1 EBAC CME Credit.
The European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively. European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for Continuing Medical Education (ACCME) and the Royal College of Physicians and Surgeons of Canada. Through an agreement between EBAC® and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of having participated in an activity eligible for AMA PRA Category 1 Credit. EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
How to earn your CME credit:
In order to obtain your CME credit and acquire your certificate, please launch the activity and complete the interactive patient case study before completing the multiple-choice assessment.
The European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.
Through an agreement between EBAC® and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
Any queries, please email: [email protected]
This CME activity is supported by an educational grant by Cytokinetics.
This course is intended for healthcare professionals practicing in Cardiology.
There are 10 questions post-webinar, and these will require a pass mark of 70% or higher to collect credit.
This educational activity is free of charge.
Following this course you will be able to:
- Discuss the burden of HCM, including its prevalence worldwide
- Summarise the pathophysiology underlying HCM, and how this can impair cardiac output.
- Describe the heterogeneous nature of HCM, including the wide variety of symptoms and severities.
- Explain the importance of prompt diagnosis and the impact of appropriate treatment for improved patient outcomes.
- Discuss the current treatment options for HCM, including new targeted treatment approaches, analysing their advantages and limitations.
Professor Theodore Abraham
University of California San Francisco, UCSF Echocardiography laboratory and the UCSF HCM Center of Excellence
Disclosures: Research grant to institution from: BMS, Cytokinetics, Tenaya, Edgewise, Imbria.
Dr Michelle Michels
Erasmus MC Center of Expertise for Inherited Cardiovascular Diseases, Rotterdam, the Netherlands
Disclosures: Research grant from Bristol Myers Squibb; and consultancy and speaker fees from Bristol Myers Squibb, Cytokinetics, Alnylam, and Bayer.
Information:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) through the joint providership of Mind Hill and EMJ Learning. The European Board for Accreditation of Continuing Education for Health Professionals (EBAC) accredits Continuing Education (CE) programmes for the international medical community. Mind Hill is an EBAC accredited provider since 2023.
This activity is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1:00 hour of effective education time, and is designated for 1 EBAC CME Credit.
The European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively. European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for Continuing Medical Education (ACCME) and the Royal College of Physicians and Surgeons of Canada. Through an agreement between EBAC® and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of having participated in an activity eligible for AMA PRA Category 1 Credit. EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
How to earn your CME credit:
In order to obtain your CME credit and acquire your certificate, please launch the activity and complete the interactive patient case study before completing the multiple-choice assessment.
The European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.
Through an agreement between EBAC® and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
Any queries, please email: [email protected]
This CME activity is supported by an educational grant by Cytokinetics.